Concomitant use of steroids or phototherapy with chlormethine gel among patients with mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL): a real-world evidence study

被引：0
|
作者：
Querfeld, Christiane [1 ]
Turini, Marco [2 ]
Gor, Deval [3 ]
Angello, James T. [2 ]
Pashos, Chris [3 ]
Kim, Ellen J. [4 ]
机构：
[1] City Hope Comprehens Canc Ctr, Div Dermatol, Duarte, CA USA
[2] Helsinn Healthcare SA, Lugano, Switzerland
[3] Genesis Res LLC, Hoboken, NJ USA
[4] Univ Penn, Philadelphia, PA 19104 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2021年 / 156卷
关键词：
Chlormethine gel; registry; observational study;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Tre-P-01
引用
收藏
页码：S44 / S45
页数：2
相关论文
共 40 条
  • [1] Maintenance therapy with chlormethine gel among patients with mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL): a real-world evidence study
    Querfeld, Christiane
    Turini, Marco
    Gor, Deval
    Angello, James T.
    Pashos, Chris
    Kim, Ellen J.
    EUROPEAN JOURNAL OF CANCER, 2021, 156 : S45 - S45
  • [2] Schedule frequency of chlormethine gel for patients with mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL): A real-world evidence study
    Querfeld, Christiane
    Binder, Gary
    Turini, Marco
    Gor, Deval
    Wassel, Christina L.
    Pashos, Chris
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB77 - AB77
  • [3] Maintenance and Concomitant Therapy Use with Chlormethine Gel Among Patients with Stage IA/IB Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Real-World Evidence Study
    Querfeld, Christiane
    Nelson, Winnie W.
    Gor, Deval
    Pashos, Chris L.
    Doan, Quan, V
    Turini, Marco
    Angello, James T.
    Geskin, Larisa J.
    DERMATOLOGY AND THERAPY, 2022, 12 (12) : 2781 - 2795
  • [4] Maintenance and Concomitant Therapy Use with Chlormethine Gel Among Patients with Stage IA/IB Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Real-World Evidence Study
    Christiane Querfeld
    Winnie W. Nelson
    Deval Gor
    Chris L. Pashos
    Quan V. Doan
    Marco Turini
    James T. Angello
    Larisa J. Geskin
    Dermatology and Therapy, 2022, 12 : 2781 - 2795
  • [5] Management of mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL): focus on chlormethine gel
    Denis, Daphne
    Beneton, Nathalie
    Laribi, Kamel
    Maillard, Herve
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 2241 - 2251
  • [6] Use of mechlorethamine gel in patients diagnosed with mycosis fungoides cutaneous T-cell lymphoma (MF-CTCL): "Real-world'' experience from the Prospective Observational Study (PROVe)
    Geskin, Larissa
    Guitart, Joan
    Kim, Ellen
    Sharma, Gaurav
    Zhao, Carol
    Rengarajan, Badri
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB307 - AB307
  • [7] Mechlorethamine Hydrochloride Gel in the Treatment of Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Focus on Patient Selection and Special Considerations
    Crimp, Caitlin
    Gangal, Ameya
    Tarabadkar, Erica S.
    Shinohara, Michi M.
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 3271 - 3279
  • [8] No detectable systemic absorption of topically applied 0.02% and 0.04% chlormethine (CL) gel in patients with mycosis-fungoides cutaneous T-cell lymphoma (MF-CTCL)
    Querfeld, C.
    Scarisbrick, J.
    Quaglino, P.
    Papadavid, E.
    Romero, P. Ortiz
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (07) : S109 - S109
  • [9] Efficacy and quality of life (QoL) in patients with mycosis fungoides cutaneous T-cell lymphoma (MF-CTCL) treated with chlormethine gel and other therapies: results from the PROVe study
    Kim, E. J.
    Geskin, L. J.
    Querfeld, C.
    Girardi, M.
    Mink, D. R.
    Williams, M. J.
    Angello, J. T.
    Bailey, W. L.
    EUROPEAN JOURNAL OF CANCER, 2019, 119 : S39 - S39
  • [10] MYCOSIS FUNGOIDES-TYPE CUTANEOUS T-CELL LYMPHOMA (MF-CTCL) EPIDEMIOLOGY AND TREATMENT PATHWAYS IN FRANCE AND SPAIN: NEW INSIGHTS FOR AN ACCURATE DESCRIPTION
    D'Agostino, P.
    Lezzi, C.
    Kent, A.
    Sharp, E.
    Schmidt, F.
    Turini, M. M.
    VALUE IN HEALTH, 2019, 22 : S852 - S853
1234